Actinium Pharmaceuticals
ATNM
ATNM
59 hedge funds and large institutions have $29.8M invested in Actinium Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 6 closing their positions.
Holders
59
Holders Change
+1
Holders Change %
+1.72%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
18
Reduced
18
Closed
6
Calls
$535K
Puts
$359K
Net Calls
+$176K
Net Calls Change
-$235K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$1.01M |
| 2 |
2
Barclays
London,
United Kingdom
|
$192K |
| 3 |
3
Jane Street
New York
|
$151K |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$2.89M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$6.93M |
Top Sellers
| 1 |
1
BlackRock
New York
|
$8.59M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$165K |
| 3 |
3
Goldman Sachs
New York
|
$78.6K |
| 4 |
BGIM
4
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
$740K |
| 5 |
5
Invesco
Atlanta,
Georgia
|
$58.7K |
